ALLO vs QCOM · rev $22.0K vs P/E 16, rev $44.28B
Allogene Therapeutics Inc (ALLO) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
ALLO currently screens at market cap $258.1M. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the ALLO and QCOM stock pages for the full models.
Not investment advice.